Methylene Blue Injection
Product Images NDC 71288-811

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Methylene Blue (NDC 71288-811). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel – Methylene Blue Injection, Usp 10 mL Carton (Meth Blue Carton V5)

This is information related to Methylene Blue Injection, USP. The text provides details about the composition of the injection, its usage as an intravenous solution, dosage guidelines, storage instructions, and precautions to be taken while administering the medication. It includes specifics such as the concentration of Methylene Blue per 10mL and the need for dilution with 5% Dextrose Injection.*

FDA Label Image

Structural Formula (Meth Blue Structure)

FDA Label Image

Principal Display Panel – Methylene Blue Injection, Usp 10 mL Vial Label (Meth Blue Vial V5)

This is a description of Methylene Blue Injection, USP. Each 10ml vial contains 50mg of methylene blue, with a concentration of 5mg per mL (0.5%). It is intended for intravenous use only and should be diluted with 5% Dextrose Injection. The vial should be kept at a temperature of 15° to 30°C (59-86°F), and should not be refrigerated or frozen. The manufacturer is Meitheal Pharmaceuticals based in Chicago, IL, USA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.